PROGRESSIVE SUPRANUCLEAR PALSY
Clinical trials for PROGRESSIVE SUPRANUCLEAR PALSY explained in plain language.
Never miss a new study
Get alerted when new PROGRESSIVE SUPRANUCLEAR PALSY trials appear
Sign up with your email to follow new studies for PROGRESSIVE SUPRANUCLEAR PALSY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug injection tested in fight against rare brain disorder
Disease control CompletedThis study tested whether regular injections of an experimental drug called GV1001 could help slow the progression of Progressive Supranuclear Palsy (PSP), a rare and serious brain disorder. For 24 weeks, 78 patients in Korea received either one of two doses of GV1001 or a placeb…
Matched conditions: PROGRESSIVE SUPRANUCLEAR PALSY
Phase: PHASE2 • Sponsor: GemVax & Kael • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Year-Long test for rare brain disease treatment
Disease control CompletedThis study followed patients for an extra year to check the long-term safety and see if the drug GV1001 continued to help control Progressive Supranuclear Palsy (PSP), a rare and serious brain disorder. It involved 67 patients who had already completed a previous trial, giving th…
Matched conditions: PROGRESSIVE SUPRANUCLEAR PALSY
Phase: PHASE2 • Sponsor: GemVax & Kael • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC
-
Scientists map how dementia affects Brain's thinking center
Knowledge-focused CompletedThis research study aimed to understand how the brain's frontal lobe works during thinking tasks like categorization and analogical reasoning. Researchers compared brain activity in 130 participants—some with frontal dementia conditions and some healthy volunteers—using cognitive…
Matched conditions: PROGRESSIVE SUPRANUCLEAR PALSY
Phase: NA • Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Mar 13, 2026 15:05 UTC